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Abstract
Background: Due to increasing life expectancy, more and more older people are suffering from dementia and
comorbidities. To date, little information is available on place of death for dementia patients in Germany. In
addition, the association of place of death and comorbidities is unknown.
Methods: A population-based cross-sectional survey was conducted in Westphalia–Lippe (Germany), based on
the analysis of death certificates from 2011. Individuals with dementia ≥ 65 years were identified using the
documented cause of death. In this context, all mentioned causes of death were included. In addition, ten
selected comorbidities were also analyzed. The results were presented descriptively. Using multivariate logistic
regression, place of death was analyzed for any association with comorbidities.
Results: A total of 10,364 death certificates were analyzed. Dementia was recorded in 1646 cases (15.9%; mean age 86.3
± 6.9 years; 67.3% women). On average, 1.5 ± 1.0 selected comorbidities were present. Places of death were distributed as
follows: home (19.9%), hospital (28.7%), palliative care unit (0.4%), nursing home (49.5%), hospice (0.9%), no details (0.7%).
The death certificates documented cardiac failure in 43.6% of cases, pneumonia in 25.2%, and malignant tumour in 13.4%.
An increased likelihood of dying in hospital compared to home or nursing home, respectively, was found for
the following comorbidities (OR [95%-CI]): pneumonia (2.96 [2.01–4.35], p = 0.001); (2.38 [1.75–3.25], p = 0.001);
renal failure (1.93 [1.26–2.97], p = 0.003); (1.65 [1.18–2.32], p = 0.003); and sepsis (13.73 [4.88–38.63], p = 0.001);
(7.34 [4.21–12.78], p = 0.001).
Conclusion: The most common place of death in patients with dementia is the retirement or nursing home,
followed by hospital and home. Specific comorbidities, such as pneumonia or sepsis, correlated with an increased
probability of dying in hospital.
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Background
The proportion of people developing a dementia-related
disease increases with increasing age. Older people’s
state of health is also usually characterized by
comorbidity — i.e., they suffer from several diseases
simultaneously.
In Germany, it is estimated that about 1.6 million
people are currently diagnosed with dementia [1]. The
absolute numbers of affected people have been estimated
as 8.7 million in Europe in 2013 [2] and 46.8 million
worldwide in 2015 [3]. Due to the age-dependency of
the disease process and continually rising life expect-
ancy, particularly in Western industrialized countries,
the prevalence of the disease will increase further in the
future. On the basis of predicted population trends in
Germany, the number of patients with the condition will
increase by around 40,000 annually and will rise to
about 3 million by 2050 [1].
There is currently no treatment for dementia and the
condition usually progresses very slowly. The duration of
the disease cannot be reliably predicted in the individual
case. Overall, the age-specific mortality rate is at least
double that for individuals without dementia [4, 5].
Sampson et al. demonstrated in a prospective cohort of
people with advanced dementia in the UK that 37% of
these people died during a 9-months observational
period [6]. Similar mortality rates have been reported in
other countries [7–9].
During the course of the disease, people with severe
dementia lose almost all their learned skills and abilities.
They consequently require extensive nursing and med-
ical support in many life situations. This represents a
major health-policy and social challenge. It also affects
end-of-life care. The disease is increasingly regarded as
life-limiting by physicians, and the need for palliative
care in patients in the advanced staged of dementia has
been noted [10, 11].
Place of death is regarded as a kind of quality indicator
for evaluating end-of-life care. Surveys on place of death
show that most people clearly prefer to die at home
rather than in institutions [12–14].
The place of death is not listed in official statistics in
Germany, since the information given on the death
certificate is not further analyzed by the relevant author-
ities. Studies on place of death for the general population
in Germany show that hospitals are by far the most
frequent place of death, followed by the home environ-
ment, retirement or nursing homes, hospices, and pallia-
tive care units [15].
Hardly any data regarding place of death are available for
individuals with dementia in Germany. Escobar Pinzon et al.
showed that in the federal state of Rhineland–Palatinate in
2008 42.4% of those with dementia died at home, followed
by nursing homes (26.9%), hospitals (26.2%) and palliative
institutions (hospices and/or palliative units; 3.2%) [16].
International studies show that individuals with dementia
mainly die in institutions, with nursing homes and hospitals
to some extent, being the most frequent place of death in
most countries [16–22].
Older people with dementia often suffer from mul-
tiple additional diseases [23]. On average, two to eight
other chronic diseases are present [24, 25]. In 3971
patients with dementia aged over 64 receiving care
from family physicians in Spain, at least three other
diagnoses were present in 70% with the most frequent
being arterial hypertension, osteoarthrosis (in both
women and men), as well as anxiety disorder/neurosis
in women and benign prostate hypertrophy in men
[26]. In the UK, arterial hypertension (53.4%), chronic
pain (33.5%), depression (23.5%), presbyacusis (22.3%),
coronary heart disease (21.6%), and chronic renal fail-
ure (20.8%) were the most frequent comorbidities in
4999 patients with dementia [27]. Overall, patients
with dementia have a higher prevalence of complex
situations that indicate functional limitations (includ-
ing immobility, dysphagia, and impaired hearing), de-
pression, and frailty syndrome (reduced physical
activity, weakness, fatigue, weight loss) [28]. In
addition, these patients have more often emergency
hospital admissions compared to patients without de-
mentia, and the number of hospital admissions in-
creases with the severity of the disease [29, 30]. The
reasons for hospital admission are often bronchial
and urogenital infections, falls, or fractures, as well as
delirium [31, 32]. Although it appears obvious from
the clinical point of view that comorbidities contrib-
ute to the place of death for patients with dementia,
hardly any scientific evidence is available on the
topic.
The aim of the present study was to describe the place
of death of patients with dementia in Germany on the
basis of analyzed death certificates and to investigate the
extent to which specific comorbidities are associated
with the place of death.
Methods
Design
This was a population-based epidemiological cross-sectional
study based on death certificates for the study region in
2011.
Study region
The study region included selected urban areas (the cities of
Bochum and Münster) and rural areas (the districts of
Borken and Coesfeld) in Westphalia–Lippe in the federal
state of North Rhine–Westphalia (Germany). On December
31st 2010, the study region’s population was 1,243,957,
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representing 1.5% of the total population of Germany at
that time.
Study data
The study used a complete dataset of death certificates for
the study region. In all, 12,914 death certificates were
available for 2011, which were archived in each local pub-
lic health department and had to be analyzed on site due
to data protection regulations. Information was collected
about age, sex, time of death, place of death, manner of
death, and cause of death. The main focus of the analysis
was on the cause of death in patients with dementia. Ten
other selected diseases documented by the physicians on
the death certificate were also examined: pneumonia,
aspiration, sepsis, cardiac failure, myocardial infarction,
intracerebral bleeding (ICB) and/or cerebral stroke, malig-
nant neoplasia, chronic obstructive pulmonary disease
(COPD), renal failure, and Parkinson’s disease.
As cases of dementia mainly become clinically mani-
fest in the elderly, the analyses was restricted to de-
ceased persons whose age at death was 65 or over and
who had a natural cause of death (n = 10,364).
Documentation of cause of death
In accordance with German law, all deaths have to be
certified by a physician. The form and structure of the
death certificate are the responsibility of each federal
state in Germany and are not standardized. In all 16 fed-
eral states, however, the question of the cause of death
largely follows the scheme set out by the World Health
Organization. Efforts have been made to develop a
standard federal death certificate, but the project has so
far been blocked by several states. It is also intended to
introduce an electronic death certificate in Germany, as
has been demanded at the European Union level, but
this project has not yet been implemented [33].
The present study used death certificates from the
state of North Rhine–Westphalia. Documentation of the
cause of death is specified as follows here: “Section I,”
I.a) “immediate cause of death” — i.e., the disease that
led directly to death; I.b) “this is a result of” — i.e., a dis-
ease that is derived from the underlying condition and
causally contributed to the death; I.c) “the underlying
cause” — i.e., the disease causally leading to death and
giving rise to the diseases described in I.a and I.b. In
addition, the physician is able to record other diseases
that were not immediately part of the causal chain lead-
ing to the death in “Section II.” The heading “Epicrisis”
also provides an opportunity to document additional
medical details on the sequence of the disease, accident
occurrence, etc.
The analysis of death certificates is carried out in a
standardized fashion in all federal states. The
non-confidential section (time of death, manner of
death, place of death) and the confidential section (cause
of death) in the medical certificate are first sent to the
local civil registry office where the patient was registered
with his or her place of residence, and an official death
statistic bulletin is drawn up. During this official proced-
ure, the medical information about place of death is
unfortunately not included. The death certificate is then
sent on to the responsible public health office. There,
the medical officer of health checks among other mat-
ters whether the stated diagnoses are compatible with
the sex and age of the deceased and in general whether
sufficient information about the cause of death is given.
In a third step, the information is then transferred to the
state statistical offices, where it is combined with the
death statistic bulletin. Trained signatories once again
check the medical details on the cause of death and
finally determine the underlying disease in accordance
with the regulations in the International Statistical Clas-
sification of Diseases and Related Health Problems
(ICD), volume 2 [34]. This involves monocausal statistics
on the cause of death — i.e., only one underlying disease
is recorded and represented (“one cause per death”). The
other diagnoses noted on the death certificate are
ignored. Finally, this information is sent to the Federal
Office of Statistics, which publishes annually
cause-of-death statistics for the whole of Germany.
In contrast to the official cause-of-death statistics in
Germany, the present study made use of all medical
information available on the cause of death (Sections I.a,
I.b, I.c, Section II, and epicrisis) in order to identify
patients with dementia and other selected diseases.
However, the medically documented diagnosis was not
further differentiated according to Section I, Section II,
or epicrisis. The reason for this was the highly
time-consuming logistic effort involved in obtaining the
documentation in each local public health office in the
study region.
Persons with dementia-related disease
In accordance with ICD-10, patients with a
dementia-related disease constituted the study popula-
tion if the medical details on the cause of death were
described as follows: Alzheimer’s disease (F00, G30), vas-
cular dementia (F01), dementia in other diseases classi-
fied elsewhere (F02), and unspecified dementia (F03).
Comorbidities
All death certificates were analyzed for ten additional co-
morbid conditions and classified in accordance with
ICD-10: pneumonia (J12.0–J18.9), aspiration (J69.0,
J60.1, J69.8; J95.4; T17.2–T17.9), sepsis (A39.2–39.4,
A40, A41, B37.7, R52.7), cardiac failure (I09, I25.1,
I25.3–I25.9, I50), myocardial infarction (I21, I22, I24,
I25.2), intracerebral bleeding (ICB) or cerebral stroke
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(I60, I61, I62, I63, I64, I69), malignant neoplasia (C00–
C97), chronic obstructive pulmonary disease (COPD)
(J41, J42, J44), renal failure (N17, N18, N19), and
Parkinson’s disease (G20).
Definition of place of death
The place of death was classified in the study as home
environment, hospital, palliative care unit, retirement
home or nursing home, hospice, and other locations.
The category “home environment” combined the
deceased person’s private residence as well as other pri-
vate homes that were not the home of the deceased indi-
vidual. Hospitals, psychiatric clinics, and sanatoriums
were included under “hospital” as place of death. Pallia-
tive care units were counted as a separate place of death.
The category “retirement or nursing home” included all
institutions involving old age homes, retirement homes,
geriatric care homes, sheltered housing, and short-term
care. “Other locations” represented other public areas,
family physicians’ practices, and leisure centers.
Statistical analyses
To assess the prevalence, the absolute number of indi-
viduals aged 65 or over with a dementia-related disease
was counted and related to the overall number of deaths
in that age group (relative frequency). An analysis strati-
fied by sex and specific age groups (65–69, 70–74, 75–
79, 80–84, 85–89, 90–94, ≥ 95 years) was also carried
out. In addition, the data were subjected to direct age
standardization. For this purpose, the age-specific
mortality rate in the study population was calculated,
weighted with the age-specific rate in a standard popula-
tion, and added up. The “Old European Standard Popu-
lation” was used as the standard population.
The characteristics of the study population were listed
by sex, age, selected comorbidities and number of co-
morbidities (no.: 1, 2, 3, 4, ≥ 5), and a subdivision rela-
tive to place of death was also carried out. It was
investigated whether individuals who died at home with
dementia differed significantly from those with a differ-
ent place of death (hospital, palliative care unit, retire-
ment or nursing home, hospice, other location, no
details). For this purpose, unpaired t-tests were used for
continuous data and the chi-squared test for categorical
data, or in the case of cell numbers fewer than five,
Fisher’s exact test was used.
Places of death were represented using absolute and
relative frequencies, and sex-specific differences were
tested using the chi-squared test. As no deaths at “other
places” were observed, that category was not listed fur-
ther in the results.
An association between “explanatory factors” and the
dependent variable “place of death” was tested using a
multivariate logic regression model. The target variable
“home” (0) was investigated relative to the place of death
“hospital” (1) and the place of death “retirement or nurs-
ing home” (1); in a second step, the place of death “re-
tirement or nursing home” (0) was investigated relative
to the places of death “hospital” (1). Due to very low
results, the places of death “palliative care unit” (n = 6)
and “hospice” (n = 14) were not subjected to multivariate
regression analysis.
“Independent factors” were sex (women (1) vs. men
(0)) and the median age of the deceased persons (≥ 86.7
y (1) vs. < 86.7 y (0)). In addition, the multivariate re-
gression model considered all ten comorbidities —
pneumonia, aspiration, sepsis, cardiac failure, myocardial
infarction, intracerebral bleeding (ICB) or cerebral
stroke, malignant tumour, chronic obstructive pulmon-
ary disease (COPD), renal failure, and Parkinson’s dis-
ease. The process of modeling followed primarily clinical
aspects. The aim was to analyze the statistical impact of
each explanatory variable (sex, age, diseases) on the
dependent variable “place of death”. Accordingly, we
used a block method and not a stepwise regression pro-
cedure (forward selection or backward elimination).
Under these conditions, we accepted a possibly poorer
adjustment of the statistical model. Odds ratios with
95% confidence intervals were generated from this
model. The Wald test was used to examine whether the
independent variable had any significant influence on
the target variable. The quality of the statistical model
was expressed using Nagelkerke pseudo-R2 coefficients.
To minimize the global increase in the probability of
alpha error due to multiple testing of the same sample,
the significance level was set at p < 0.01 (two-sided). All
analyses were carried out using the statistics program
IBM SPSS Statistics, version 23.
Ethics approval and data protection
The study was submitted to the Ethics Committee of the
Ruhr University of Bochum and approved after examin-
ation (registry no. 4522-12). Letters were sent to the
public health offices requesting access to the death cer-
tificates archived there. Permission to collect data and
carry out the scientific analysis, while observing legal
data protection regulations, was officially granted. The
data had to be recorded locally in the public health
offices.
Results
A total of 10,364 death certificates of patients who had
died at the age of 65 or over were analyzed. Dementia
was described in 1646 cases, representing a relative fre-
quency of 15.9%. A larger proportion of women (19.5%)
than men (11.4%) were affected. The standardized preva-
lence of all individuals with a dementia-related disease
was 8.0% (women 9.0%, men 6.9%; data not shown). One
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in ten deceased persons aged 75–79 suffered from de-
mentia. In the 95 or older age group, one in four men
and one in three women were affected by the disease
(Fig. 1).
Overall, 67.3% of the deceased patients were women.
Of deaths in retirement or nursing homes from demen-
tia, two-thirds were women. Of deaths in hospital, just
under half were men. The mean age was 86.3 ± 6.9 years.
On average, 1.5 ± 1.0 other comorbidities were present.
No comorbidity was present in 14.9% of cases, one add-
itional condition was present in 40.6%, and three comor-
bidities were present in 10.6% of the cases. The most
frequent accompanying disease was cardiac failure
(43.6%). Pneumonia was documented in one-quarter of
the cases, and cancer in just over one in ten. Patients
with dementia who died in hospital suffered significantly
more often from pneumonia, aspiration, sepsis, and
renal failure compared to patients with dementia who
died at home. Patients with dementia who died in hos-
pices had malignant tumours more often compared to
those who had received terminal care in the home envir-
onment (71.4% vs. 12.8%; p < 0.01) (Table 1).
Patients with dementia dying in hospital had a high
proportion of infectious diseases (such as pneumonia or
sepsis), aspiration, and renal failure in comparison with
other places of death that were investigated. In contrast,
septic conditions were only rarely noted in death certifi-
cates for those who died at home (1.2%), while cardiac
failure was the most frequent in that location with
45.9%. In retirement or nursing homes, the frequency of
documented pneumonia was similar to that for deaths in
the home environment (19.9%) which was much lower
in comparison with hospitals (39.1%). In hospices, de-
mentia patients mainly died of tumours (Fig. 2).
Retirement or nursing homes were by far the most fre-
quent place of death. Approximately every second
patient died there. Hospitals represented the second
most frequent place of death (28.7%). Only one in five
deaths occurred in the home environment. Palliative
care units and hospices played a subordinate role, with a
total of 1.3%. Stratified by sex, women died more often
in retirement or nursing homes, while men by contrast
died more often in hospital (Fig. 3).
In the multivariate regression analysis, very elderly pa-
tients with dementia (86 years, ≥ 0.5 quantile) and
women had a higher odds of dying in retirement or
nursing homes compared to the home setting (OR 1.59
[95%-CI 1.21–2.08], p = 0.001; OR 1.55 [95%-CI 1.16–
2.08], p = 0.003) and a lower odds of dying in hospital
compared to retirement or nursing homes (OR 0.50
[95%-CI 0.38–0.64], p = 0.001; OR 0.50 [95%-CI 0.38–
0.66], p = 0.001). There was a statistical association
between pneumonia, sepsis, and renal failure and hospi-
tals as a place of death. In comparison with deaths at
home, the odds of dying in hospital was three times
higher when there was a medically documented pneu-
monia (OR 2.96 [95%-CI 2.01–4.35], p = 0.001), while
in the presence of renal failure it was twice as high
(OR 1.93 [95%-CI 1.26–2.97], p = 0.003) and with sep-
sis 14 times higher (OR 13.73 [95%-CI 4.88–38.63],
p = 0.001). Similarly, in comparison with deaths in
retirement or nursing homes, the odds of dying in
hospital was also higher in the presence of pneumo-
nia (OR 2.38 [95%-CI 1.75–3.25], p = 0.001), sepsis
Fig. 1 Prevalence of persons aged 65 or over with a death certificate recording dementia
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(OR 7.34 [95%-CI 4.21–12.78], p = 0.001) or renal
failure (OR 1.65 [95%-CI 1.18–2.32], p = 0.003). There
was also a correlation between the diagnosis of
myocardial infarction and an increased probability
of dying in hospital (OR 2.52 [95%-CI 1.45–4.36],
p = 0.001) (Table 2).
Discussion
Patients with dementia most often died in retirement or
nursing homes, followed by hospitals and the home en-
vironment. Palliative care units and hospices as places of
death played only a minor role. An association was seen
between selected comorbidities and an increased likeli-
hood of dying in hospital.
In the present study, nearly one in two deaths among
patients with dementia occurred in retirement or nurs-
ing homes in Westphalia-Lippe (Germany). This finding
is not surprising, as it reflects the high level of nursing
care required by dementia patients. Relatives who are
caring for people with dementia usually have a strong
wish to care for and look after the patient in the shared
home environment. However, relatives dealing with de-
mentia patients on a daily basis are exposed to a large
number of problems and challenges. The time demands
involved in caring often conflict with the carer’s own
family, and working life. Persons with dementia may also
show depressive or even aggressive behavior in the
course of their disease, as well as developing restlessness
and/or a marked urge for movement. This can lead to a
high level of physical and above all emotional burden on
caring relatives, which may even cause social isolation
[35, 36]. Caregivers usually belong to the patient’s imme-
diate family (first-degree relatives, children, spouses), or
more rarely they may be friends or other people linked
to the patient [37]. If relatives struggle to cope with the
situation they can get potentially support from a home
Table 1 Characteristics of deceased persons with dementia aged 65 or over, stratified by place of death
Overall
(n = 1646)
Home
(n = 327)
Hospital
(n = 473)
Palliative care unit
(n = 6)
Retirement or nursing home
(n = 815)
Hospice
(n = 14)
No details
(n = 11)
% n % n % n % n % n % n % n
Women 67.3 1108 64.5 211 55.4* 262 83.3 5 75.6* 616 42.9 6 72.7 8
Men 32.7 538 35.5 116 44.6* 211 16.7 1 24.4* 199 57.1 8 27.3 3
Age (mean / SD) 86.3 ± 6.9 85.8 ± 6.8 84.2* ± 6.5 81.5 ± 7.4 87.8* ± 6.8 81.1 ± 6.7 84.5 ± 5.4
Age (median, 0.5 quantile) 86.7 86.4 84.6 84.9 88.2 81.9 83.9
Age (0.25 quantile) 82.0 81.7 80.1 74.5 83.6 79.3 80.7
Age (0.75 quantile) 90.7 90.4 88.9 86.7 92.0 85.5 86.7
Age, women (mean / SD) 87.7 ± 6.6 87.2 ± 6.6 85.8 ± 6.4 80.7 ± 7.9 88.8* ± 6.4 82.6* ± 2.4 84.7 ± 6.3
Age, men (mean / SD) 83.3 ± 6.5 83.4 ± 6.4 82.1 ± 6.0 85.5 ± 0 84.7 ± 6.8 80.0 ± 8.7 84.1 ± 2.9
Pneumonia 25.2 415 19.3 63 39.1* 185 0 0 19.9 162 28.6 4 9.1 1
Aspiration 10.0 164 9.5 31 15.6* 74 0 0 7.1 58 7.1 1 0 0
Sepsis 5.7 93 1.2 4 14.4* 68 0 0 2.3 19 7.1 1 9.1 1
Cardiac failure 43.6 718 45.9 150 44.2 209 50.0 3 42.8 349 14.3 2 45.5 5
Myocardial infarction 4.8 79 4.6 15 7.2 34 0 0 3.7 30 0 0 0 0
ICB and/or cerebral stroke 13.0 214 13.1 43 10.8 51 16.7 1 14.2 116 14.3 2 9.1 1
Malignant tumour 13.4 220 12.8 42 13.3 63 33.3 2 12.3 100 71.4* 10 27.3 3
COPD 6.1 100 5.8 19 7.6 36 16.7 1 5.2 42 7.1 1 9.1 1
Renal failure 15.4 253 12.5 41 19.7* 93 33.3 2 14.4 117 0 0 0 0
Parkinson’s disease 9.4 154 8.0 26 11.4 54 16.7 1 9.0 73 0 0 0 0
Comorbidity (mean) 1.5 ± 1.0 1.3 ± 0.9 1.8 ± 1.0 1.7 ± 0.8 1.3 ± 0.9 1.5 ± 0.7 1.1 ± 0.8
0 Comorbidity 14.9 245 16.8 55 5.9* 28 0.0 0 19.6 160 0.0 0 18.2 2
1 Comorbidity 40.6 669 45.3 148 33.4* 158 50.0 3 42.3 345 57.1 8 63.6 7
2 Comorbidities 31.1 512 27.8 91 39.1* 185 33.3 2 28.0 228 35.7 5 9.1 1
3 Comorbidities 10.6 175 8.6 28 15.9* 75 16.7 1 8.5 69 7.1 1 9.1 1
4 Comorbidities 2.2 36 1.5 5 4.9* 23 0.0 0 1.0 8 0.0 0 0.0 0
≥ 5 Comorbidities 0.5 9 0.0 0 0.8 4 0.0 0 0.6 5 0.0 0 0.0 0
COPD chronic obstructive pulmonary disease, ICB intracerebral bleeding, SD standard deviation
*Specific place of death vs. place of death “at home” (chi-squared test) P < 0.01
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Fig. 2 Specific comorbid conditions in persons aged 65 or over with dementia, stratified by place of death
Fig. 3 Place of death in persons aged 65 or over with dementia, stratified by gender
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help, a day or temporary nurse or a nursing service.
However, these measures are often only effective in
the shorter term. Alternative residential forms are
available, such as “sheltered housing” or “dementia
apartment-sharing,” but a move to a nursing home is
often the only practicable way of ensuring care.
This study has shown that (unsurprisingly) it is mainly
very elderly people and women who die in retirement
and nursing homes. This observation is explained by
demographic change and changes in social life. Life
expectancy has been increasing for decades in the West-
ern industrialized countries, and this applies to Germany
as well. In this country, the mean life expectancy is cur-
rently 83.1 years for women and 78.2 years for men [38].
Due to their lower life expectancy, men are more likely
to be survived by their partners, and this also increases
the probability that they will be cared for by relatives at
home at the end of their lives. Also, due to the increas-
ing age, there is a greater likelihood that women will be
widowed or living alone when they are elderly and, with
increasing physical problems will be dependent on as-
sistance from strangers or institutions. The results of the
2011 population census in Germany also indicate that
more and more people are living alone. The proportion
of people living alone, for example, increased from
15.6% in 1996 to 19.6% in 2011 [39].
Surveys have shown that most people would prefer to
die at home [12–14] and this also applies to people with
dementia-related diseases [16]. The findings of the
present study are in contrast to this wish of patients:
only one in five persons with dementia died at home.
The reasons for this remain speculative, but it may again
be linked to excessive stress on relatives caring for
the patient and show that there is a need for relevant
action to be taken in health care policy. This need
has been recognized by the relevant German political
decision-making body, and measures have been imple-
mented [40]. The legal meaning of the term “status of
requiring care” has been redefined and extended to
mental and psychological illnesses. Patients with
dementia have consequently had their previous benefit
entitlement from the nursing insurance fund
upgraded. In addition, relatives who have had to stop
working in order to provide care are now receiving
improved financial support from the state.
Advanced-stage dementia is increasingly being
regarded as a terminal disease leading to death [10, 11,
41, 42]. Palliative care is appropriate in dementia, since
it represents a “disease that does not respond to curative
treatment” or a “life-threatening disease,” as dementia it-
self is not curable. The treatment approach aims at
achieving improvements in quality of life. The results of
the present study show that in-patient palliative and
hospice institutions were only playing a minor role in
2011 in comparison with all other places of death. Only
0.4% of all dementia patients who died received
end-of-life care in a palliative care unit, and only 0.9% of
them received care in a hospice. There might be several
reasons for this observation. First, a health economic as-
pect. There were only 32,1 palliative care unit beds and
40,2 hospice beds in the study region relative to a popu-
lation of 1 million — corresponding to two-thirds of the
maximum number recommended by the European As-
sociation for Palliative Care (EAPC) [43]. Thus, there
Table 2 Association between place of death and specific comorbidities in persons aged 65 or over with dementia
Hospital (1)
vs. home (0)
Retirement or nursing home (1)
vs. home (0)
Hospital (1) vs. retirement or
nursing home (0)
OR (95% CI) p value OR (95% CI) p value OR (95% CI) p value
Women (1) vs. men (0) 0.80 (0.58–1.11) 0.186 1.55 (1.16–2.08)* 0.003 0.50 (0.38–0.66)* 0.001
Age (median), ≥ 86.7 y (1) vs. < 86.7 y (0) 0.78 (0.57–1.08) 0.133 1.59 (1.21–2.08)* 0.001 0.50 (0.38–0.64)* 0.001
Pneumonia, yes (1) vs. no (0) 2.96 (2.01–4.35)* 0.001 1.25 (0.85–1.84) 0.249 2.38 (1.75–3.25)* 0.001
Aspiration, yes (1) vs. no (0) 1.26 (0.76–2.09) 0.380 0.66 (0.39–1.12) 0.126 1.68 (1.09–2.59) 0.018
Sepsis, yes (1) vs. no (0) 13.73 (4.88–38.63)* 0.001 1.71 (0.57–5.16) 0.338 7.34 (4.21–12.78)* 0.001
Cardiac failure, yes (1) vs. no (0) 1.29 (0.94–1.78) 0.113 0.82 (0.62–1.07) 0.145 1.51 (1.16–1.97) 0.012
Myocardial infarction, yes (1) vs. no (0) 2.19 (1.13–4.23) 0.019 0.86 (0.45–1.66) 0.661 2.52 (1.45–4.36)* 0.001
ICB /cerebral stroke, yes (1) vs. no (0) 1.01 (0.63–1.60) 0.984 1.10 (0.75–1.61) 0.642 0.87 (0.60–1.28) 0.471
Malignant tumour, yes (1) vs. no (0) 1.19 (0.75–1.87) 0.450 1.03 (0.69–1.53) 0.888 1.26 (0.87–1.83) 0.230
COPD, yes (1) vs. no (0) 1.28 (0.69–2.37) 0.439 0.98 (0.55–1.75) 0.957 1.42 (0.85–2.36) 0.182
Renal failure, yes (1) vs. no (0) 1.93 (1.26–2.97)* 0.003 1.15 (0.78–1.70) 0.483 1.65 (1.18–2.32)* 0.003
Parkinson’s disease, yes (1) vs. no (0) 1.39 (0.82–2.35) 0.227 1.20 (0.75–1.94) 0.449 1.12 (0.74–1.70) 0.577
Nagelkerke R2 (goodness of fit) 0.179 0.040 0.221
OR odds ratio, CI confidence intervals, COPD chronic obstructive pulmonary disease, ICB intracerebral bleeding
*P < 0.01
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was a need for implementing further inpatient palliative
care and hospice services in this region in 2011. Second,
the life expectancy of patients with dementia. In many
cases, the natural course of the disease often exceeds the
official requirements that patients should only be admit-
ted to hospices when the medical estimate of life expect-
ancy is less than 3–6 months.
Several investigations indicate that patients with de-
mentia are at increased risk of hospital admission com-
pared to people without dementia [29, 30, 43–46]. The
reasons for this are complex [6, 31, 32, 47–49]. The
most frequent causes include respiratory and urogenital
infections, fall-related injuries, neurological and psychi-
atric causes (syncope, confusion, delirium), pressure
sores, and nutritional disturbances. There is a consensus
in the research findings that many of these diseases
could have been treatable in home care or in in-patient
care institutions, so that hospital admission could have
been avoided [50, 51]. Psychosocial factors also affect
hospital admissions — for example, when the previous
carer suddenly becomes unavailable.
Generally, a hospital stay is a severe burden for many
people with dementia and it is also associated with a
number of risks. These include prolongation of the
hospitalization period, a decline in physical functional
abilities, increased frequencies of nosocomial infections,
and an increased likelihood of not being able to return
to the home environment after the hospital treatment
[52]. Sampson et al. concluded that an unplanned hos-
pital stay significantly shortens the median survival time
in patients with dementia [53].
In the present study group of deceased individuals in
the general population aged 65 or older with dementia,
in-patient deaths represented 28.7% of cases. A similar
percentage was reported by Houttekier et al. in a
European survey in 2003 [18]. The mean percentage of
dementia patients aged 65 or over who died in hospital
in that study was 27.4%, including all countries investi-
gated (Belgium, Netherlands, England, Wales, and
Scotland). The Netherlands showed a very low percent-
age, with only 2.8% of deaths occurring in in-patients. In
this country, some general practitioners (“verpleeghui-
sarts”) work exclusively in nursing homes enabling them
to monitor the state of health of nursing-home patients
tightly and offer medical treatment in a timely manner
when physical changes occur. In most cases, hospital ad-
missions can be avoided.
The medical information on cause of death that was
analyzed in the present study showed that the deceased
dementia patients had been suffering from a mean of 1.5
of the selected comorbidities. Cardiac failure was the
most frequent comorbidity documented in the death
certificates with almost one in two deaths, with the diag-
noses of pneumonia, renal failure and malignant
tumours following in frequency. Cardiovascular diseases
are the most common cause of death in Germany,
followed by cancers. The diagnosis of dementia is
already in third place [54]. The prevalence of cardiac
failure, like that of dementia, increases with increasing
age [55, 56], and this may have contributed to the high
prevalence of cardiac failure in the present sample.
Many patients with advanced dementia also suffer from
dysphagia [57], which may make fluid intake much more
difficult. This can lead to dehydration and prerenal kid-
ney failure. In addition, there is a risk of aspiration of
fluid and food particles potentially resulting in pneumo-
nia leading to sepsis and multiple-organ failure causing
death finally [58]. In several autopsy studies, pneumonia
was the most frequent cause of death [59, 60]. These
findings are supported by clinical data. Mitchell et al.
[7], for example, noted in the CASCADE study that
41.1% of the patients developed at least one episode of
pulmonary infection during the 18-month follow-up
period. The infection was associated with a high mortal-
ity rate. In the Netherlands, the three most frequent
causes of death in nursing-home residents with demen-
tia were dehydration (38%), cardiovascular diseases
(19%), and respiratory infections (18%) [61]. In the
present study, the death certificates described pneumo-
nia in 25.2% of cases and aspiration in 10.0%. Pneumo-
nia and/or aspiration were particularly frequent on the
death certificates of dementia patients who died in hos-
pital (39.1 and 15.6%, respectively). Compared to home
or nursing home deaths, the odds of dying in hospital
with documented pneumonia was two to three times
higher, and with aspiration by a factor of 1.3 or 1.7
higher. In addition, deceased hospital patients often had
sepsis (14.4%), renal failure (19.7%), and myocardial in-
farction (7.2%). These results suggest that there is a high
intensity of treatment in hospital at the end of life in de-
mentia patients. Unfortunately, the study was not able to
provide any further information on this.
Care for patients with dementia in the last phase of
their lives represents a special challenge, since those
affected are often unable to express their treatment
preferences directly themselves, while established,
evidence-based treatment pathways for this phase of
disease are still largely lacking. Research results show-
ing that physical symptoms are widespread in persons
with dementia and that they even increase before
death [6, 7, 16, 61].
In Germany, a new law was passed in 2015 to improve
hospice and palliative care [62]. The law aims to
strengthen comprehensive hospice and palliative care in
Germany by implementing targeted measures in statu-
tory health insurance and social care insurance. The
measures are intended among other things to ensure
networking among medical and nursing services, as well
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as attendant hospice services, and to guarantee cooper-
ation among the health-care providers involved. The aim
is to strengthen palliative care and hospice approaches
in in-patient care institutions and hospitals and to offer
information to health-insurance policy-holders in a tar-
geted way about the hospice and palliative care services
available, as well as enabling nursing-home residents to
carry out individualized care planning for the last phase
of life. The statutory framework conditions have been
set out, but they require specific arrangements and a
financial basis so that everyone in Germany — and par-
ticularly those with dementia — can be offered adequate
palliative medical care adapted to their individual needs
at the end of their lives.
Strengths and limitations
This study is based on the largest dataset (n = 10,364)
analyzed to date on place of death in patients with de-
mentia in Germany. No details were available regarding
the place of death for only 0.7% of deceased persons
with dementia aged 65 or over. As the study is related
only to the selected study region of Westphalia–Lippe,
the results are not representative of Germany as a
whole.
The study design used a population-based cross-sectional
survey. This methodological approach is very suitable for
hypothesis generation, but it does not allow any causal con-
clusions to be drawn. The validity of such studies is also
limited, since only a few variables are available for analysis.
Important determining factors contributing to the place of
death — such as the patient’s and/or relatives’ preference
for place of death, marital status (single, married, divorced),
residential situation (living alone or together with one or
more other people), the amount of care required,
information about treatments (chemotherapy, surgery,
intensive-care procedures), links to a specialist team for pal-
liative care, etc. — were not available for the analysis and
could not be further explored for data protection reasons.
The medical details provided about the cause of death
require critical reflection. For reasons of the logistics
involved in obtaining the data, for example, this study
did not differentiate among causes of death relative to
the underlying disease, contributing factors and the final
direct cause of death. On the other hand, for dementia
and ten other diseases, it was possible to include all
available information about the cause of death, which
would otherwise not have been taken into account in
the official statistics for cause of death. In consequence,
the determined prevalence of dementia can be regarded
as particularly reliable. The medical details about
dementia given in the death certificates usually did not
include either any information about the severity of the
disease nor when it had started, so that in this respect
no conclusions could be drawn. It should also be
critically noted that the duration of the diseases investi-
gated was not taken into account in any way in the re-
cording and analysis of the data, since this information
could not be accurately traced from the medical details.
It is known that dementia-related diseases are not
always perceived by physicians as representing an under-
lying disease leading to death, and are consequently
often not stated on death certificates [63]. This affects
dementia patients who are being cared for at home more
often than those in nursing homes. Due to this docu-
mentation practice, the frequency of dementia observed
in the present study, particularly in the home environ-
ment, may be lower than is really the case.
The quality of the data given in death certificates is
generally viewed critically. The form of the medical
documentation contributes to this [33]. Illegible hand-
writing and varying choices of words to describe diagno-
ses often make it difficult to classify the medical details
in accordance with ICD-10. A lack of knowledge on the
part of physicians involved about the purpose of the de-
tails given (establishing a causal chain) also contributes
to this. In addition, physicians often do not have any
precise medical information about the deceased person’s
clinical history. Without such knowledge, however, a
precise cause of death can only be established with
difficulty.
Conclusion
The most common place of death in people with demen-
tia was the retirement and nursing home, followed by
hospital. Only one-fifth died in the home environment.
End-of-life care for people with dementia represents a
special challenge and requires a person-centered care
approach with staff qualified in palliative care. In this
context, existing nursing and medical care services and
hospice services need to be further developed and ex-
tended to ensure that all individuals with dementia can
receive adequate palliative care in accordance with their
own individual needs at the end of their lives.
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